p53 transcriptional gene network

No Pathway Network information available for p53 transcriptional gene network

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with p53 transcriptional gene network SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Xeroderma pigmentosum, variant typeEnrichmentDDB2, ERCC5, POLH, XPC6.14
2Muir-torre syndromeEnrichmentMLH1, MSH24.31
3Laryngeal squamous cell carcinomaEnrichmentPTEN, TNFRSF10B3.84
4Mismatch repair cancer syndrome 1EnrichmentMLH1, MSH23.54
5Autoimmune lymphoproliferative syndromeEnrichmentFAS, FASLG3.54
6Focal cortical dysplasia, type iiEnrichmentMTOR, TSC23.54
7Cerebral malariaEnrichmentICAM1, TNF3.54
8Isolated focal cortical dysplasia type iiEnrichmentMTOR, TSC23.54
9Endometrial cancerEnrichmentMLH1, MSH2, PTEN3.39
10HemimegalencephalyEnrichmentMTOR, PTEN3.32
11Ovarian cancerEnrichmentERCC5, MSH2, PTEN, TSC2, XPC3.15
12Squamous cell carcinoma, head and neckEnrichmentPTEN, TNFRSF10B3.00
13Lung cancerEnrichmentFAS, FASLG, MLH12.85
14Mitochondrial neurogastrointestinal encephalomyopathyEnrichmentRRM2B, SCO22.77
15Lynch syndrome 1EnrichmentMLH1, MSH22.68
16Familial colorectal cancerEnrichmentMLH1, MSH22.68
17Uterine corpus cancerEnrichmentMSH2, PTEN2.59
18Colorectal cancerEnrichmentAURKA, BAX, MLH1, MSH22.49
19Gastric cancerEnrichmentMLH1, MSH2, PTEN2.47
20Hereditary breast carcinomaEnrichmentMLH1, MSH2, PTEN2.45
21Lynch syndromeEnrichmentMLH1, MSH22.32
22RhabdomyosarcomaEnrichmentMSH2, PTEN2.26
23GliosarcomaEnrichmentMGMT, MSH22.26
24Giant cell glioblastomaEnrichmentMGMT, MSH22.21
25Hereditary breast ovarian cancer syndromeEnrichmentMLH1, MSH2, PTEN2.17
26Vacterl association with hydrocephalusEnrichmentPTEN2.15
27Stomatin-deficient cryohydrocytosis with neurologic defectsEnrichmentSLC2A12.15
28Immunodeficiency 38 with basal ganglia calcificationEnrichmentISG152.15
29Lynch syndrome 2EnrichmentMLH12.15
30Cardiomyopathy, familial hypertrophic, 6EnrichmentPRKAG22.15
31Plasminogen activator inhibitor-1 deficiencyEnrichmentSERPINE12.15
32Mitochondrial dna depletion syndrome 8bEnrichmentRRM2B2.15
33Papillary tumor of the pineal regionEnrichmentPTEN2.15
34Glycogen storage disease of heart, lethal congenitalEnrichmentPRKAG22.15
35Systemic lupus erythematosus 10EnrichmentIRF52.15
36Glutathione peroxidase deficiencyEnrichmentGPX12.15
37Epilepsy, idiopathic generalized 12EnrichmentSLC2A12.15
38Olmsted syndrome 2EnrichmentPERP2.15
39Ataxia-telangiectasia-like disorder 2EnrichmentPCNA2.15
40Inflammatory bowel disease 14EnrichmentIRF52.15
41Glioma susceptibility 2EnrichmentPTEN2.15
42Skeletal muscle glycogen content and metabolism quantitative trait locusEnrichmentPRKAG32.15
43Mismatch repair cancer syndrome 2EnrichmentMSH22.15
44Immunodeficiency 65 viral infectionsEnrichmentIRF92.15
45Erythrokeratodermia variabilis et progressiva 7EnrichmentPERP2.15
46Rectal benign neoplasmEnrichmentMSH22.15
47Ascending colon cancerEnrichmentMSH22.15
48Autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defectEnrichmentSCO22.15
49Ovarian cystEnrichmentMSH22.15
50Epilepsy with myoclonic absencesEnrichmentSLC2A12.15
51Congenital plasminogen activator inhibitor type 1 deficiencyEnrichmentSERPINE12.15
52Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephalyEnrichmentPIDD12.15
53Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndromeEnrichmentPTEN2.15
54Rrm2b mitochondrial dna maintenance defectsEnrichmentRRM2B2.15
55Hereditary cryohydrocytosis with reduced stomatinEnrichmentSLC2A12.15
56HepatoblastomaEnrichmentERCC5, MSH22.03
57MalariaEnrichmentICAM1, TNF1.95
58Inherited cancer-predisposing syndromeEnrichmentMLH1, MSH2, PTEN, TSC21.86
59Fanconi renotubular syndrome 1EnrichmentRRM2B1.86
60Hyperprolinemia, type iiEnrichmentALDH4A11.86
61Dystonia 9EnrichmentSLC2A11.86
62Xeroderma pigmentosum, complementation group cEnrichmentXPC1.86
63Rod-cone dystrophy, sensorineural deafness, and fanconi-type renal dysfunctionEnrichmentRRM2B1.86
64Xeroderma pigmentosum, complementation group eEnrichmentDDB21.86
65Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 5EnrichmentRRM2B1.86
66LymphangioleiomyomatosisEnrichmentTSC21.86
67Glut1 deficiency syndrome 1EnrichmentSLC2A11.86
68Mitochondrial dna depletion syndrome 8aEnrichmentRRM2B1.86
69Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic faciesEnrichmentPOLK1.86
70Adams-oliver syndrome 5EnrichmentNOTCH11.86
71Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 2EnrichmentRRM2B1.86
72Xeroderma pigmentosum, complementation group aEnrichmentXPC1.86
73Spastic paraplegia 73, autosomal dominantEnrichmentCPT1C1.86
74Cebalid syndromeEnrichmentMTOR1.86
75Myopia 6EnrichmentSCO21.86
76Immunodeficiency 127EnrichmentTNF1.86
77Glucose transporter type 1 deficiency syndromeEnrichmentSLC2A11.86
78Smith-kingsmore syndromeEnrichmentMTOR1.86
79Xeroderma pigmentosum group cEnrichmentXPC1.86
80Vacterl with hydrocephalusEnrichmentPTEN1.86
81Juvenile polyposis of infancyEnrichmentPTEN1.86
82Xeroderma pigmentosum group eEnrichmentDDB21.86
83Breast cancerEnrichmentMLH1, MSH2, PTEN1.81
84Bladder cancerEnrichmentCDKN1A, PTEN1.76
85Prostate cancerEnrichmentPOLK, PTEN1.76
86Tuberous sclerosis 1EnrichmentTSC21.68
87Immunodeficiency 98 with autoinflammation, x-linkedEnrichmentFASLG1.68
88Granulomatous disease, chronic, autosomal recessive, 2EnrichmentNCF21.68
89Polycystic kidney disease, infantile severe, with tuberous sclerosisEnrichmentTSC21.68
90Xeroderma pigmentosum, complementation group gEnrichmentERCC51.68
91Mitochondrial complex iv deficiency, nuclear type 2EnrichmentSCO21.68
92Glut1 deficiency syndrome 2EnrichmentSLC2A11.68
93Psoriatic arthritisEnrichmentTNF1.68
94Tuberous sclerosis 2EnrichmentTSC21.68
95Cerebrooculofacioskeletal syndrome 3EnrichmentERCC51.68
96Keratosis follicularis spinulosa decalvansEnrichmentSAT11.68
97Chromosome 17q23.1-q23.2 deletion syndromeEnrichmentSLC2A11.68
98Mutilating palmoplantar keratoderma with periorificial keratotic plaquesEnrichmentPERP1.68
99HamartomaEnrichmentTSC21.68
100Xanthinuria, type iiEnrichmentTSC21.68
101Cellular ependymomaEnrichmentMSH21.68
102Tanycytic ependymomaEnrichmentMSH21.68
103Papillary ependymomaEnrichmentMSH21.68
104T-cell acute lymphoblastic leukemiaEnrichmentBAX1.68
105Migraine without auraEnrichmentTNF1.68
106Idiopathic camptocormiaEnrichmentRRM2B1.68
107Xeroderma pigmentosum group gEnrichmentERCC51.68
108Clear cell ependymomaEnrichmentMSH21.68
109KeratoacanthomaEnrichmentNOTCH11.68
110Vogt-koyanagi-harada diseaseEnrichmentFAS1.68
111FucosidosisEnrichmentFUCA11.56
112Lynch syndrome 4EnrichmentMSH21.56
113Tuberous sclerosisEnrichmentTSC21.56
114Pediatric systemic lupus erythematosusEnrichmentSAT11.56
115GliomaEnrichmentPTEN1.56
116Benign ependymomaEnrichmentMSH21.56
117Pseudomyogenic hemangioendotheliomaEnrichmentSERPINE11.56
118Systemic lupus erythematosusEnrichmentIRF5, TNF1.52
119Kearns-sayre syndromeEnrichmentRRM2B1.46
120Macrocephaly/autism syndromeEnrichmentPTEN1.46
121Cox deficiency, infantile mitochondrial myopathyEnrichmentSCO21.46
122GlioblastomaEnrichmentMSH21.46
123HemangiomaEnrichmentPTEN1.46
124PolyneuropathyEnrichmentERCC51.46
125Vascular dementiaEnrichmentTNF1.46
126Acute megakaryocytic leukemiaEnrichmentPTEN1.46
127Rare isolated myopiaEnrichmentSCO21.46
128Diffuse cutaneous systemic sclerosisEnrichmentIRF51.46
129Xeroderma pigmentosum-cockayne syndrome complexEnrichmentERCC51.46
130West syndromeEnrichmentSLC2A1, TSC21.42
131Congenital nervous system abnormalityEnrichmentFUCA1, PTEN, TSC21.42
132Nervous system diseaseEnrichmentFUCA1, PTEN, TSC21.42
133Cowden syndrome 1EnrichmentPTEN1.38
134Cerebrooculofacioskeletal syndrome 1EnrichmentERCC51.38
135Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1EnrichmentRRM2B1.38
136Mitochondrial dna depletion syndrome 1EnrichmentSCO21.38
137Limited sclerodermaEnrichmentIRF51.38
138Polycystic kidney disease 1 with or without polycystic liver diseaseEnrichmentTSC21.32
139Multiple endocrine neoplasia, type iEnrichmentCDKN1A1.32
140Thyroid cancer, nonmedullary, 2EnrichmentPTEN1.32
141Renal cell carcinoma, papillary, 1EnrichmentMTOR1.32
142Adams-oliver syndromeEnrichmentNOTCH11.32
143Polycystic kidney disease 1EnrichmentTSC21.32
144Follicular thyroid carcinomaEnrichmentPTEN1.32
145Paroxysmal dystoniaEnrichmentSLC2A11.32
146Overgrowth syndromeEnrichmentMTOR1.32
147Mitochondrial dna depletion syndrome 4bEnrichmentSCO21.26
148Alternating hemiplegia of childhoodEnrichmentSLC2A11.26
149Hypoplastic left heart syndromeEnrichmentNOTCH11.26
150Rheumatoid arthritisEnrichmentIRF51.21
151Myoclonic-atonic epilepsyEnrichmentSLC2A11.21
152Adult hepatocellular carcinomaEnrichmentTSC21.21
153Chronic granulomatous diseaseEnrichmentNCF21.21
154Colonic benign neoplasmEnrichmentMLH11.21
155Primary biliary cholangitisEnrichmentIRF51.21
156Cowden syndromeEnrichmentPTEN1.21
157MelanomaEnrichmentPTEN1.17
158Pectus excavatumEnrichmentERCC51.13
159AsthmaEnrichmentTNF1.13
160Meningioma, familialEnrichmentPTEN1.13
161MeningiomaEnrichmentPTEN1.09
162Aortic valve disease 1EnrichmentNOTCH11.06
163Breast-ovarian cancer, familial 1EnrichmentMSH21.06
164Acute promyelocytic leukemiaEnrichmentPML1.06
165Alzheimer's diseaseEnrichmentTNF1.06
166Aortic aneurysm, familial thoracic 1EnrichmentNOTCH11.03
167Renal cell carcinoma, nonpapillaryEnrichmentMTOR1.00
168Autosomal dominant polycystic kidney diseaseEnrichmentTSC21.00
169Rare genetic intellectual disabilityEnrichmentMTOR1.00
170Wolff-parkinson-white syndromeEnrichmentPRKAG20.97
171Melanoma, cutaneous malignant 1EnrichmentMGMT0.95
172Human immunodeficiency virus type 1EnrichmentCCL20.92
173Behcet syndromeEnrichmentFAS0.90
174Diffuse large b-cell lymphomaEnrichmentPTEN0.90
175Developmental and epileptic encephalopathy 1EnrichmentSLC2A10.79
176Tetralogy of fallotEnrichmentNOTCH10.78
177StrabismusEnrichmentSLC2A10.76
178Autism spectrum disorderEnrichmentPTEN, TSC20.75
179Connective tissue diseaseEnrichmentNOTCH10.70
180Familial hypertrophic cardiomyopathyEnrichmentPRKAG20.68
181EpilepsyEnrichmentSLC2A10.61
182Benign epilepsy with centrotemporal spikesEnrichmentSLC2A10.60
183Centralopathic epilepsyEnrichmentSLC2A10.58
184Hypertrophic cardiomyopathyEnrichmentPRKAG20.58
185Familial thoracic aortic aneurysm and aortic dissectionEnrichmentNOTCH10.57
186Sensorineural hearing lossEnrichmentRRM2B0.54
187Myeloma, multipleEnrichmentAURKA0.49
188Primary ovarian insufficiencyEnrichmentTHBS10.47
189Dilated cardiomyopathyEnrichmentSCO20.37
190Mitochondrial diseaseEnrichmentRRM2B0.34
191MicrocephalyEnrichmentSLC2A10.24
192Retinitis pigmentosaEnrichmentRRM2B0.11

Loading...
Loading...
Loading...